PARTNER 3 Trial - Aortic Valve-in-Valve is a study to check if the SAPIEN 3/SAPIEN 3 Ultra heart valve is safe and works well for people with a worn-out aortic valve. The study is called a "prospective, single-arm, multicenter study," which means it looks at the future effects of the valve in different places, but all patients get the same treatment.
Who can join: You can join if you have a failing aortic valve (a valve in your heart that doesn’t work right) with certain measurements and if doctors think you are at low or medium risk for surgery. You must also agree to the study rules and sign a consent form.
Who cannot join: You can't join if you have other heart problems, like severe valve issues or recent heart attacks, or if you have certain health conditions that make the procedure too risky.
- The study involves only one specific heart valve treatment.
- Your heart team must agree that the treatment will benefit you.
- Ensure you understand the study and agree to participate.